Your session is about to expire
← Back to Search
Spinal Cord Stimulation
Noninvasive spinal stimulation with gait training for Stroke
N/A
Recruiting
Led By Arun Jayaraman, PT, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up session 1 (baseline test, initial visit), midpoint, post intervention, 3 month follow-up, 6 month follow-up, 12 month follow-up
Awards & highlights
Study Summary
This trial will test if a non-invasive spinal cord stimulator can help improve gait and balance for people with hemiplegia caused by stroke.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ session 1 (baseline test, initial visit), midpoint, post intervention, 3 month follow-up, 6 month follow-up, 12 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~session 1 (baseline test, initial visit), midpoint, post intervention, 3 month follow-up, 6 month follow-up, 12 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Gait Symmetry
Secondary outcome measures
4. Locomotion assessment for intra limb coordination using electromyography (EMG) on GaitRite
Change Static in Balance
Change corticospinal excitability
+5 moreOther outcome measures
Change in Dynamic Balance
Change in Gait Symmetry on Treadmill
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Noninvasive Spinal Stimulation with Gait TrainingExperimental Treatment1 Intervention
May receive up to 50 min of locomotion training with transcutaneous spinal cord stimulation. However, the amount of time spent in side-lying locomotion training, treadmill training and overground training will depend on individual tolerance and progression.
Group II: Healthy Control GroupExperimental Treatment1 Intervention
Participant in the Healthy Control Group will participate in up to 3 assessment sessions in order to obtain comparative data for Spinal Motor Evoked Potentials (MEPs), lower extremity MVC's, sidelying EMG data and overground EMG data
Group III: Conventional Gait TrainingActive Control1 Intervention
May receive up to 50 min of locomotion training without transcutaneous spinal cord stimulation. However, the amount of time spent in side-lying locomotion training, treadmill training and overground training will depend on individual tolerance and progression.
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
192 Previous Clinical Trials
14,795 Total Patients Enrolled
69 Trials studying Stroke
6,255 Patients Enrolled for Stroke
University of California, Los AngelesOTHER
1,528 Previous Clinical Trials
10,276,761 Total Patients Enrolled
34 Trials studying Stroke
6,280 Patients Enrolled for Stroke
Arun Jayaraman, PT, PhDPrincipal Investigator - Shirley Ryan AbilityLab
Shirley Ryan AbilityLab
22 Previous Clinical Trials
2,812 Total Patients Enrolled
9 Trials studying Stroke
1,462 Patients Enrolled for Stroke
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an opportunity to join this research endeavor?
"According to clinicaltrials.gov, this medical research is currently in search of study volunteers. The trial was initially posted on August 17th 2018 and the details were most recently amended on August 31st 2020."
Answered by AI
To what extent is this medical study being conducted, in terms of the quantity of participants?
"Affirmative, the information on clinicaltrials.gov provides evidence that this medical trial is actively recruiting participants. It was initially posted in August 2018 and has been updated as recently as August 2020; 90 individuals are needed to complete the study at one particular site."
Answered by AI
Share this study with friends
Copy Link
Messenger